XML 72 R22.htm IDEA: XBRL DOCUMENT v3.25.4
Other Noncurrent Assets and Liabilities
 12 Months Ended
Dec. 31, 2025
Other Noncurrent Assets And Liabilities [Abstract]  
Other Noncurrent Assets and Liabilities Other Noncurrent Assets and Liabilities
Other noncurrent assets as of December 31, 2025 and 2024, consists of the following (in millions):
 20252024
Accrued accounts receivable and contract assets$568 $606 
Operating lease ROU assets (1)231 230 
Equity security investments193 191 
Customer inducements140 162 
Deferred compensation plan assets159 161 
Derivatives283 120 
Other136 279 
Total Other noncurrent assets$1,710 $1,749 

Other noncurrent liabilities as of December 31, 2025 and 2024, consists of the following (in millions):
 20252024
Derivatives$819 $633 
Operating lease liabilities (1)178 177 
Deferred compensation plan liabilities163 151 
Purchased software with long-term payment arrangements98 146 
Pensions164 127 
Deferred revenue166 117 
Other98 90 
Total Other noncurrent liabilities$1,686 $1,441 

(1)See Note 16 for information about operating leases.

Equity Security Investments

The Company holds various equity securities without readily determinable fair values. These securities primarily represent strategic investments made by the Company as well as investments obtained through acquisitions. Such investments totaled $193 million and $191 million at December 31, 2025 and 2024, respectively, and are included within Other noncurrent assets
on the consolidated balance sheets. The Company accounts for these investments at cost, less impairment, and adjusts the carrying values for observable price changes from orderly transactions for identical or similar investments of the same issuer. These adjustments are generally considered Level 2-type fair value measurements. The Company records realized and unrealized gains and losses on these investments as well as impairment losses, as Other income (expense), net on the consolidated statements of earnings (loss) and recorded net (losses) gains of $(3) million, $(5) million and $(48) million for the years ended December 31, 2025, 2024 and 2023, respectively, related to these investments. The net loss recorded for the 2023 period primarily relates to impairments. .